FDA Says Strong Safety Data A Must For COVID-19 Vaccine Approval For Kids

The FDA said that clinical trials testing COVID-19 vaccines for children are expected to include a monitoring period of at least two months after half the participants get the shots to ensure safety.

The comments come as vaccine makers race to submit clinical data seeking regulatory approval for vaccines in children below 12.